First patient enrolled in Australia in prostate cancer trial
The first of a planned 160 patients has been enrolled on a new cancer trial…
Browsing: enzalutamide
The Oncology Journal Club Episode 6: GI Update with Fotios Loupakis and much more…
The Oncology Podcast, brought to you by www.oncologynews.com.au, is proud to present the next episode…
New clues about why some metastatic prostate cancers don’t respond to enzalutamide
Over the last decade, enzalutamide and similar drugs have led to significant tumour control and…
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
The Food and Drug Administration (FDA) approved enzalutamide or patients with metastatic castration-sensitive prostate cancer…
ASCO 2019: Adding enzalutamide to standard first-line treatment improves survival for men with metastatic hormone-sensitive prostate cancer
An interim analysis of the international randomised, phase III ENZAMET trial found that 80% of…
Enzalutamide shows efficacy in preventing aggressive prostate cancer becoming metastatic, deadly
Men with non-metastatic castrate-resistant prostate cancer and a quickly rising PSA level present a medical…
Researchers create a drug to extend the lives of men with prostate cancer
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him…
Breakthrough study stops fat-eating prostate cancer cells
Patients with castration resistant prostate cancer (CRPC) usually have a poor prognosis. In part, this…
How highs and lows in testosterone levels ‘shock’ prostate cancer cells to death
A strategy of alternately flooding and starving the body of testosterone is producing good results…